1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

        <em id="8sgz1"><label id="8sgz1"></label></em>
      2. <em id="8sgz1"><label id="8sgz1"></label></em>
        <em id="8sgz1"></em>
        <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

        <button id="8sgz1"></button>
        west china medical publishers
        Keyword
        • Title
        • Author
        • Keyword
        • Abstract
        Advance search
        Advance search

        Search

        find Keyword "凝血" 79 results
        • A Study on the Correlation between Traumatic Coagulopathy and Traumatic Brain Injury

          目的:探討腦損傷患者凝血功能水平與顱腦損傷傷情轉歸的相關性。方法:收集70例顱腦損傷患者的臨床資料,傷者抽取靜脈血2 mL,進行凝血功能檢測,分析結果與臨床資料等分別采用SPSS 11.5軟件進行χ2檢驗和logistic回歸分析。結果:在13例凝血功能異常患者中有5例(38%)傷情加重(較入院時腦內血腫體積增大,遲發性血腫等),明顯高于凝血功能正常而傷情加重者(12%,Plt;0.05);單因素和多因素logistic回歸分析提示凝血功能異常時腦損傷傷情加重的危險因素。結論:腦創傷后凝血功能異常時顱腦損傷患者傷情加重的危險因素。

          Release date:2016-09-08 09:56 Export PDF Favorites Scan
        • 重組組織型纖溶酶原激活劑對機體凝血酶原時間和纖維蛋白含量的影響

          Release date:2016-08-29 09:20 Export PDF Favorites Scan
        • 兩種不同循環預沖方法對維持性血液透析患者復用透析器凝血的影響

          目的比較無肝素鈉注射液(肝素)循環預沖法與肝素循環預沖法對復用透析器凝血與透析器復用次數的影響。 方法采用自身前后對照研究設計,于2013年5月-6月對接受維持性血液透析治療的39例患者采用肝素循環預沖法與無肝素循環預沖法各2周,比較兩種方法對復用透析器凝血程度及透析器復用次數的影響。 結果39例患者中,在無肝素循環預沖階段,患者失訪3例(7.7%),完成研究36例(92.3%);完成肝素循環預沖法66次,無肝素循環預沖法63次。36例患者經無肝素循環預沖法與肝素循環預沖法后,復用透析器的凝血程度與復用次數的差異均無統計學意義(P>0.05)。 結論兩種循環預沖法對復用透析器凝血與復用次數的影響差異較小,但無肝素循環預沖較為安全簡便,患者出血風險較小,值得臨床進一步推廣驗證。

          Release date:2016-12-27 11:09 Export PDF Favorites Scan
        • Changes on Perioperative Coagulation Function of Orthotopic Liver Transplantation inPatients with Advancing Chronic Hepatopathy and Fulminant Hepatitis

          目的 比較進展性慢性肝病及重癥肝炎患者原位肝移植(OLT)圍手術期凝血功能的變化。方法 回顧性分析我中心2004年1月至2005年12月期間行OLT治療進展性慢性肝病及重癥肝炎患者各37例的圍手術期血小板(PLT)、凝血酶原時間(PT)、活化部分凝血活酶時間(APTT)及纖維蛋白原(FIB)的變化。結果 2組患者除術前PT、APTT,術后第5 d PLT、FIB和術后第7 d FIB的差異有統計學意義外(plt;0.05),其余時段2組患者的PLT、PT、APTT及FIB 間差異均無統計學意義(Pgt;0.05), 提示重癥肝炎患者凝血功能損害更為嚴重; OLT術后,2組患者的凝血功能均逐漸恢復正常, 但并非完全同步。結論 進展性慢性肝病與重癥肝炎患者OLT圍手術期凝血功能變化顯著,應注意監測及處理,但術后2組間各指標間比較差異并不明顯。

          Release date:2016-09-08 11:07 Export PDF Favorites Scan
        • Present Research Situation of Factor Ⅴ Leiden and Factor Ⅱ G20210A Mutation Expressed in Different Ethnic Population

          Release date:2016-09-08 10:38 Export PDF Favorites Scan
        • 老年患者凝血機制及血管內皮細胞在體外循環中的變化

          目的 從凝血機制和血管內皮細胞(EC)的角度探討老年患者體外循環(ECC)的特點. 方法 20例心瓣膜置換術患者按不同的年齡分為兩組,每組10例,對照組:年齡20~40歲;實驗組:年齡60歲以上.觀察兩組術后出血量、輸血量、全血激活凝血時間(ACT)和ECC中肝素用量;分別于術前、ECC 30分鐘、ECC 60分鐘和術后32小時測定靜脈血中6-酮-前列腺素F1α(6-K-PGF1α,酶聯免疫吸附測定法)、組織型纖溶酶激活物(t-PA,發色底物法)活性和EC的變化. 結果 實驗組患者術后出血和輸血量比對照組均顯著增加 (P=0.0023,0.0154);維持正常ACT時間, 實驗組患者肝素用量較少,但兩組比較差別無顯著性意義;ECC 30分鐘、ECC 60分鐘和術后32小時,實驗組6-K-PGF1α、t-PA低于對照組,EC脫落數顯著增高. 結論 老年風濕性心瓣膜病患者血管EC對ECC的耐受性差,在ECC術中做好EC和血液保護非常重要.

          Release date:2016-08-30 06:32 Export PDF Favorites Scan
        • The Effects of Sleeping-inclued Hypoxema at Different Time and Level on Pulmonary Emphysema and of Coagulation System Function in Rats with Pulmonary Emphysema

          Objective To investigate whether the sleep-induced hypoxemia ( SIH) at different time and different level have different effects on pulmonary emphysema and coagulation systemfunction in the rats with pulmonary emphysema. Methods Thirty Wistar rats were randomly divided into three groups( n = 10 in each group) . All rats were exposed to cigarette smoke twice a day ( 30 min each time) . From29th day on, the rats in Group A ( pulmonary emphysema with short SIH) were also exposed to mixed gas of 12. 5% oxygen for 1. 5 hours during sleeping time every day ( the expose time was divided into 4 periods, 22. 5 min each) . The rats in Group B ( pulmonary emphysema with mild SIH) were also exposed to mixed gas of 15% oxygen for three hours during sleeping time every day( the expose time was divided into 4 periods, 45 min each) . The rats in Group C( pulmonary emphysema with standard SIH) were also exposed to mixed gas of 12. 5% oxygen for three hours during sleeping time every day( the expose time was divided into 4 periods,45 min each) . After continuous exposure for 56 days, the rats were sacrificed. Semi-quantitative image analytic method was employed for histopathological analysis including pathological score of lungs, mean linear intercept ( MLI) and mean alveolus number( MAN) . ATⅢ, FIB, vWF, FⅧ were measured. Results All animals in three groups manifested the histopathological features of emphysema. Pathological scores of lungs and MLI of every group were significantly different from each other( F = 21. 907, F = 18. 415, all P lt; 0. 05) , Group A [ ( 61. 90 ±4. 25) % , ( 92. 45 ±1. 78) μm] and Group B[ ( 64. 60 ±3. 95) % , ( 92. 80 ±3. 65) μm] were significantly lower than Group C[ ( 73. 30 ±3. 86) % , ( 99. 32 ±2. 81) μm, q= 8. 96, q =6. 84, q = 12. 64, q =9. 65, all P lt; 0. 05] . Levels of FIB were significantly different among three groups ( F = 20. 592, P lt; 0. 05) while FIB in Group A[ ( 189. 98 ±5. 29) mg/ dL] and Group B[ ( 182. 70 ±2. 78) mg /dL] were significantly lower than that in Group C[ ( 198. 40 ±7. 37) mg/ dL, q = 4. 86, q= 9. 07, all P lt; 0. 05] , and FIB in Group A was significantly higher than that in Group B( q = 4. 20, P lt; 0. 05) . Levels of FⅧ were significantly different from each other( F = 33. 652, P lt;0. 05) while FⅧ in Group A[ ( 232. 26 ±4. 17) % ]and Group B[ ( 242. 53 ±14. 50) % ] were significantly lower than that in Group C[ ( 303. 25 ±32. 93) % ,q= 10. 73, q = 9. 18, all P lt; 0. 05] . Conclusions Pulmonary emphysema and hypercoagulable states increases with time and severity of SIH in rats with pulmonary emphysema. The elevated activity of blood coagulation factor may be a critical role in the hypercoagulable states.

          Release date:2016-09-14 11:25 Export PDF Favorites Scan
        • 鼻內鏡下凝血酶加明膠海綿局部填塞治療鼻腔嗅裂區出血

          目的 評價鼻內鏡下凝血酶加明膠海綿局部填塞治療鼻腔嗅裂區出血的臨床療效。 方法 2007年2月-2009年8月應用鼻內鏡明確16例鼻腔嗅裂區出血患者,使用凝血酶加明膠海綿局部填塞止血。 結果 16例均一次填塞后止血,術后1個月復診無再次出血,明膠海綿均已排出。 結論 鼻內鏡下凝血酶加明膠海綿局部填塞治療鼻腔嗅裂區出血療效確切,患者痛苦少,是治療鼻腔嗅裂區出血的一種有效方法。

          Release date:2016-09-08 09:47 Export PDF Favorites Scan
        • DIAGNOSIS AND TREATMENT OF COAGULOPATHY IN PATIENT WITH SEVERE HEPATIC CIRRHOSIS UNDERWENT ORTHOTOPIC LIVER TRANSPLANTATION

          Objective To preliminarily summarize the diagnosis and treatment of coagulopathy in patient with severe hepatic cirrhosis who underwent orthotopic liver transplantation (OLT). Methods Preoperative coagulability, the replacement therapy by coagulation factors and platelet pre-and intraoperatively, intra-operative bleeding amount and blood transfusion amount and the relation to the postoperative course were analyzed retrospectively in 6 patients with severe hepatic cirrhosis who underwent OLT in the last year. Results All of the 6 patients had a Child-c preoperative hepatic function, 2 with prolongation of bleeding time. All of the 6 had a decrease of platelet count, with a mean platelet count of 25.3×109/L. Mean prolongation of prothrombin time was 10.7 seconds as compared with controls. Mean prolongation of activated partial thromboplastin time was 23.1 seconds as compared with controls. Mean fibrinogen was 1.5 g/L. Mean pre- and intra- operative transfusion of fresh frozen plasma was 788 ml, platelet 7.1×1012, cryopreciptitate 5.5 units, fibrinogen 2.8 grams and lyophilized prothombin complex concentrate (LPCC) 1 700 units. The first 4 cases in the early period had a mean bleeding amount of 8 672.5 ml, with a mean transfusion of 9 215.0 ml. One of the 4 with the most massive intraoperative bleeding was complicated by severe internal milieu disturbance, DIC and fungus infection and died of the infection. Postoperatively the last 2 cases in the late period had a complete preoperative replacement of coagulation factors and platelet and had a only mean bleeding amount of 2 700 ml with a mean transfusion amount of 3 638 ml. Conclusion We initially consider that a preoperative complete replacement of coagulation factors and platelet according to the coagulability tests may lessen intraoperative bleeding and transfusion and make the patient an uneventful postoperative course.

          Release date:2016-09-08 02:00 Export PDF Favorites Scan
        • Role of thrombospondin-1 active fragment VR-10 synthetic peptide on rhesus choroidal-retinal endothelial cell

          ObjectiveTo investigate the effects of thrombospondin-1 active fragment (TSP-1) synthetical peptide VR-10 on proliferation and migration of rhesus choroidal-retinal endothelial (RF/6A) cell and the expressions of apoptosis relative genes in RF/6A cell. MethodsThe survival rate of RF/6A cell were detected by methyl thiazolyl tetrazolium, and migration ability was measured by transwell chamber after exposure to 1.0 μg/ml TSP-1 and synthetic peptide VR-10 (0.1, 1.0, 10.0 μg/ml) for different times (6, 12, 24, 48 hours). Caspase-3 and factor associated suicide (FAS) protein levels were measured by Western blot. The mRNA level of bcl-2 and FAS ligand (FASL) were measured by reverse transcription-polymerase chain reaction (RT-PCR). ResultsThe survival rate of RF/6A cells was determined by the treatment time and concentration of TSP-1(1.0 μg/ml) and the synthetic peptide VR-10 (0.1, 1.0, 10.0 μg/ml). The lowest survival ratio of RF/6A was 78% (P < 0.001) when cells were treated by 10 μg/ml synthetic peptide VR-10 after 48 hours. TSP-1 and synthetic peptide VR-10 could inhibit migration of RF/6A cells in transwell chamber (P < 0.001). 10.0 μg/ml synthetic peptide VR-10 had the strongest effect, 1.0 μg/ml TSP-1 was the next. Migration inhibition rate was increase with the increase of the concentration of VR-10 (P < 0.001). There was no significant differences between 0.1 μg/ml and 1.0 μg/ml VR-10 (P=0.114). Western bolt showed that RF/6A cell in control group mainly expressed the 32×103 procaspase-3 forms. To 10.0 μg/ml VR-10 treated group, it showed decreased expression of procaspase-3 (32×103) and concomitant increased expression of its shorter proapoptotic forms (20×103). Compared with control group, expression of FAS peptides were significantly increased in 10.0 μg/ml VR-10 treated group. Compared with control group, expression of FasL mRNA was significantly increased in 10.0 μg/ml VR-10 treated group(t=39.365, P=0.001), but the expression of bcl-2 mRNA was decreased(t=-67.419, P=0.000). ConclusionTSP-1 and synthetic peptide VR-10 had the ability to inhibit proliferation and migration of endothelial cell, and also induce apoptosis by increasing FAS/FASL expression and repressing bcl-2 expression.

          Release date: Export PDF Favorites Scan
        8 pages Previous 1 2 3 ... 8 Next

        Format

        Content

          1. <div id="8sgz1"><ol id="8sgz1"></ol></div>

            <em id="8sgz1"><label id="8sgz1"></label></em>
          2. <em id="8sgz1"><label id="8sgz1"></label></em>
            <em id="8sgz1"></em>
            <div id="8sgz1"><ol id="8sgz1"><mark id="8sgz1"></mark></ol></div>

            <button id="8sgz1"></button>
            欧美人与性动交α欧美精品